E. Toussirot, Response to ???Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort?????? authors??? reply, Arthritis Research & Therapy, vol.16, issue.2, p.407, 2014.
DOI : 10.1080/03009740801910346
URL : https://hal.archives-ouvertes.fr/inserm-00976776

M. Meyer, J. Sellam, S. Fellahi, S. Kotti, J. Bastard et al., Serum level of adiponectin is a surrogate independent biomarker of radiographic disease progression in early rheumatoid arthritis: results from the ESPOIR cohort, Arthritis Research & Therapy, vol.15, issue.6, p.210, 2013.
DOI : 10.1111/j.1365-2265.2012.04348.x
URL : https://hal.archives-ouvertes.fr/inserm-00926603

K. Frommer, A. Schäffler, C. Büchler, J. Steinmeyer, M. Rickert et al., Adiponectin isoforms: a potential therapeutic target in rheumatoid arthritis? Ann Rheum Dis, pp.1724-1732, 2012.

M. Miller, A. Pham, J. Cho, P. Rosenthal, and D. Broide, Adiponectin-deficient mice are protected against tobacco-induced inflammation and increased emphysema, AJP: Lung Cellular and Molecular Physiology, vol.299, issue.6, pp.834-842, 2010.
DOI : 10.1152/ajplung.00326.2009
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006270

E. Toussirot, E. Grandclément, B. Gaugler, F. Michel, D. Wendling et al., CBT-506: Serum adipokines and adipose tissue distribution in rheumatoid arthritis and ankylosing spondylitis, A comparative study, Front Immunol, vol.4, p.453, 2013.

P. Dessein, A. Woodiwiss, G. Norton, L. Tsang, and A. Solomon, Independent associations of total and high molecular weight adiponectin with cardiometabolic risk and surrogate markers of enhanced early atherogenesis in black and white patients with rheumatoid arthritis: a cross-sectional study, Arthritis Research & Therapy, vol.15, issue.5, p.128, 2013.
DOI : 10.1186/ar4308